Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.31 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.31 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23919467 | 0.92 | PRKDC (0.32) | ALOX5PRKDCATM | |
| SCHEMBL4078982 | 0.90 | PLA2G2A (0.32) | ALOX5PLA2G2APLA2G4ACYP1A1CYP1A2 | |
| SCHEMBL23919295 | 0.90 | ALOX5 (0.31) | ALOX5PLA2G2APLA2G4ACYP1A1CYP1A2 | |
| SCHEMBL23919261 | 0.89 | CYP1A1 (0.34) | ALOX5PLA2G2APLA2G4ACYP1A1CYP1A2 | |
| SCHEMBL23919470 | 0.89 | PRKDC (0.31) | ALOX5PRKDCATM | |
| SCHEMBL12206429 | 0.87 | ALOX5 (0.42) | ALOX5PRKDCATMCYP1A1CYP1A2 | |
| SCHEMBL23919463 | 0.85 | ALOX5 (0.31) | ALOX5 | |
| SCHEMBL23919469 | 0.85 | PGR (0.32) | ALOX5PRKDCATM | |
| SCHEMBL23919462 | 0.84 | TNKS (0.32) | ALOX5PLA2G2APLA2G4A | |
| SCHEMBL22489303 | 0.84 | TNKS (0.31) | PLA2G2APLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | IDEMITSU KOSAN CO.,LTD. (JP) | 2021-10-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210320251-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPLIANCE | OLA1, TAS2R19, TMEM109 | ALOX5 4667/4885PRKDC 3820/4885ATM 1171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.